CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $377,176 | -71.0% | 110,934 | -64.1% | 0.00% | – |
| Q4 2023 | $1,299,522 | -69.9% | 308,675 | -25.4% | 0.00% | -100.0% |
| Q2 2023 | $4,311,129 | -61.7% | 413,736 | -74.4% | 0.00% | -50.0% |
| Q1 2023 | $11,247,740 | +280.0% | 1,613,736 | +228.7% | 0.00% | +100.0% |
| Q4 2022 | $2,960,115 | -23.5% | 490,898 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,868,276 | -49.1% | 490,898 | -12.0% | 0.00% | -50.0% |
| Q2 2022 | $7,592,583 | -23.5% | 557,868 | +10.2% | 0.00% | 0.0% |
| Q1 2022 | $9,925,837 | -38.8% | 506,162 | +7.0% | 0.00% | -33.3% |
| Q4 2021 | $16,227,000 | -19.4% | 472,962 | +28.4% | 0.00% | -25.0% |
| Q3 2021 | $20,122,000 | -16.4% | 368,406 | +12.5% | 0.00% | -20.0% |
| Q2 2021 | $24,061,000 | -46.4% | 327,444 | -33.3% | 0.01% | -50.0% |
| Q1 2021 | $44,869,000 | – | 490,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $230,000,000 | 35.34% |
| Affinity Asset Advisors, LLC | 150,000 | $11,022,000 | 3.95% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 132,300 | $9,722,000 | 0.79% |
| Renaissance Capital LLC | 56,915 | $4,182,000 | 0.66% |
| QCM Cayman, Ltd. | 2,744 | $202,000 | 0.52% |
| Green Alpha Advisors, LLC | 4,545 | $334,000 | 0.23% |
| Baillie Gifford | 5,515,262 | $405,261,000 | 0.20% |
| CSS LLC/IL | 60,000 | $4,408,000 | 0.18% |
| Caption Management, LLC | 161,400 | $11,860,000 | 0.16% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,484,000 | 0.15% |